These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 17635670
1. Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrier. Milane A, Fernandez C, Vautier S, Bensimon G, Meininger V, Farinotti R. J Neurochem; 2007 Oct; 103(1):164-73. PubMed ID: 17635670 [Abstract] [Full Text] [Related]
2. Interactions between antiparkinsonian drugs and ABCB1/P-glycoprotein at the blood-brain barrier in a rat brain endothelial cell model. Vautier S, Milane A, Fernandez C, Buyse M, Chacun H, Farinotti R. Neurosci Lett; 2008 Sep 05; 442(1):19-23. PubMed ID: 18598736 [Abstract] [Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of alfentanil in P-glycoprotein-competent and P-glycoprotein-deficient mice: P-glycoprotein efflux alters alfentanil brain disposition and antinociception. Kalvass JC, Olson ER, Pollack GM. Drug Metab Dispos; 2007 Mar 05; 35(3):455-9. PubMed ID: 17178769 [Abstract] [Full Text] [Related]
9. Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography. Hendrikse NH, Schinkel AH, de Vries EG, Fluks E, Van der Graaf WT, Willemsen AT, Vaalburg W, Franssen EJ. Br J Pharmacol; 1998 Aug 05; 124(7):1413-8. PubMed ID: 9723952 [Abstract] [Full Text] [Related]
17. A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs. Linnet K, Ejsing TB. Eur Neuropsychopharmacol; 2008 Mar 05; 18(3):157-69. PubMed ID: 17683917 [Abstract] [Full Text] [Related]